TapewireFind a company

person · Reporting owner

BIOTECH GROWTH N V

Disclosed activity across 3 companies

Tapewire entity
81732
SEC CIK
0001259869

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Radius Health, Inc.RDUS · Entity 12417310% ownerNovember 06, 2019November 08, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Radius Health, Inc.

Report date November 06, 2019 · Filed November 08, 2019

Jointly reported with BB BIOTECH AG

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,881,685 Reported balance After 2019-11-06 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2019-11-06 · Purchase · Acquired 100,000 · Balance 6,881,685

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Black Diamond Therapeutics, Inc.

Report date March 19, 2025 · Filed March 21, 2025

Jointly reported with BB BIOTECH AG

Section 16 reporting ended · disclosed 2025-03-21. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect7,517,839 Reported balance After 2025-03-19 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2025-03-19 · Sale · Disposed 1,000,000 · Balance 7,517,839

Common StockSEC Table I · non-derivativeDirect7,217,839 Reported balance After 2025-03-19 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2025-03-19 · Sale · Disposed 300,000 · Balance 7,217,839

Common StockSEC Table I · non-derivativeDirect6,217,839 Reported balance After 2025-03-19 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2025-03-19 · Sale · Disposed 1,000,000 · Balance 6,217,839

Common StockSEC Table I · non-derivativeDirect4,217,839 Reported balance After 2025-03-19 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2025-03-19 · Sale · Disposed 2,000,000 · Balance 4,217,839

Common StockSEC Table I · non-derivativeDirect3,817,839 Reported balance After 2025-03-19 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 5 · 2025-03-19 · Sale · Disposed 400,000 · Balance 3,817,839

Common StockSEC Table I · non-derivativeDirect3,233,547 Reported balance After 2025-03-19 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 6 · 2025-03-19 · Sale · Disposed 584,292 · Balance 3,233,547

Common StockSEC Table I · non-derivativeDirect2,733,547 Reported balance After 2025-03-19 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 7 · 2025-03-19 · Sale · Disposed 500,000 · Balance 2,733,547

ESSA Pharma Inc.

Report date November 01, 2024 · Filed November 05, 2024

Jointly reported with BB BIOTECH AG

Section 16 reporting ended · disclosed 2024-11-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect5,879,583 Reported balance After 2024-11-01 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2024-11-01 · Sale · Disposed 2,000,000 · Balance 5,879,583

Common SharesSEC Table I · non-derivativeDirect3,879,583 Reported balance After 2024-11-01 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2024-11-01 · Sale · Disposed 2,000,000 · Balance 3,879,583

Common SharesSEC Table I · non-derivativeDirect1,879,583 Reported balance After 2024-11-01 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2024-11-01 · Sale · Disposed 2,000,000 · Balance 1,879,583

Common SharesSEC Table I · non-derivativeDirect0 Reported balance After 2024-11-01 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2024-11-01 · Sale · Disposed 1,879,583 · Balance 0

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 05, 2018 Filed Apr 9, 2018 17:19 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $36.58 $1,828,845.00
Disclosure

SEC source: 0000899243-18-009722 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,903,799

Read SEC document
March 02, 2018 Filed Mar 6, 2018 21:23 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 80,000 $32.52 $2,601,448.00
Disclosure

SEC source: 0000899243-18-006482 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,853,799

Read SEC document
February 09, 2018 Filed Feb 12, 2018 21:54 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 75,000 $34.38 $2,578,762.50
Disclosure

SEC source: 0000899243-18-003551 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,773,799

Read SEC document
November 14, 2017 Filed Nov 16, 2017 17:16 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $26.25 $1,312,390.00
Disclosure

SEC source: 0000899243-17-026538 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,698,799

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:44 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $29.15 $1,457,575.00
Disclosure

SEC source: 0000899243-17-025497 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,648,799

Read SEC document
October 26, 2017 Filed Oct 27, 2017 19:39 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $30.95 $1,547,550.00
Disclosure

SEC source: 0000899243-17-024807 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,598,799

Read SEC document
October 25, 2017 Filed Oct 26, 2017 22:30 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $32.85 $1,642,415.00
Disclosure

SEC source: 0000899243-17-024774 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,548,799

Read SEC document
September 14, 2017 Filed Sep 15, 2017 18:05 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $32.94 $1,647,225.00
Disclosure

SEC source: 0000899243-17-022128 · doc4.xml · nonDerivative · entry 2

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,498,799

Read SEC document
September 13, 2017 Filed Sep 15, 2017 18:05 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 100,000 $33.71 $3,370,750.00
Disclosure

SEC source: 0000899243-17-022128 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,448,799

Read SEC document
September 12, 2017 Filed Sep 13, 2017 19:49 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $35.42 $1,770,820.00
Disclosure

SEC source: 0000899243-17-021997 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,348,799

Read SEC document
September 05, 2017 Filed Sep 7, 2017 17:58 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $36.75 $1,837,625.00
Disclosure

SEC source: 0000899243-17-021577 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,298,799

Read SEC document
August 16, 2017 Filed Aug 18, 2017 15:41 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 60,000 $35.98 $2,158,536.00
Disclosure

SEC source: 0000899243-17-020664 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,248,799

Read SEC document
August 10, 2017 Filed Aug 11, 2017 15:15 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 75,000 $34.26 $2,569,500.00
Disclosure

SEC source: 0000899243-17-020120 · doc4.xml · nonDerivative · entry 2

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,188,799

Read SEC document
August 09, 2017 Filed Aug 11, 2017 15:15 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 75,000 $35.67 $2,675,527.50
Disclosure

SEC source: 0000899243-17-020120 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,113,799

Read SEC document
May 30, 2017 Filed May 31, 2017 19:59 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 40,000 $34.21 $1,368,348.00
Disclosure

SEC source: 0000899243-17-014826 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,038,799

Read SEC document
May 25, 2017 Filed May 30, 2017 18:00 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 40,000 $36.25 $1,450,020.00
Disclosure

SEC source: 0000899243-17-014666 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,998,799

Read SEC document
May 18, 2017 Filed May 22, 2017 18:51 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $34.41 $1,720,345.00
Disclosure

SEC source: 0000899243-17-014021 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,958,799

Read SEC document
May 17, 2017 Filed May 18, 2017 15:21 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 18,000 $32.98 $593,661.60
Disclosure

SEC source: 0000899243-17-013647 · doc4.xml · nonDerivative · entry 2

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,908,799

Read SEC document
May 16, 2017 Filed May 18, 2017 15:21 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 17,000 $33.93 $576,725.00
Disclosure

SEC source: 0000899243-17-013647 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890,799

Read SEC document
May 12, 2017 Filed May 16, 2017 15:41 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 15,000 $34.00 $509,995.50
Disclosure

SEC source: 0000899243-17-013302 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,873,799

Read SEC document
May 09, 2017 Filed May 11, 2017 18:51 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $35.93 $1,796,480.00
Disclosure

SEC source: 0000899243-17-012775 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,858,799

Read SEC document
May 08, 2017 Filed May 9, 2017 17:05 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 22,800 $35.60 $811,629.84
Disclosure

SEC source: 0000899243-17-012438 · doc4.xml · nonDerivative · entry 2

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,808,799

Read SEC document
May 05, 2017 Filed May 9, 2017 17:05 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 20,600 $35.55 $732,282.62
Disclosure

SEC source: 0000899243-17-012438 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,785,999

Read SEC document
May 02, 2017 Filed May 3, 2017 19:12 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 75,000 $33.91 $2,542,920.00
Disclosure

SEC source: 0000899243-17-011599 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,765,399

Read SEC document
May 01, 2017 Filed May 2, 2017 17:37 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 150,000 $35.39 $5,308,605.00
Disclosure

SEC source: 0000899243-17-011379 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,690,399

Read SEC document
March 21, 2017 Filed Mar 22, 2017 21:28 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 50,000 $35.83 $1,791,625.00
Disclosure

SEC source: 0000899243-17-008398 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,540,399

Read SEC document
March 17, 2017 Filed Mar 21, 2017 16:31 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 30,000 $38.41 $1,152,249.00
Disclosure

SEC source: 0000899243-17-008279 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,490,399

Read SEC document
March 15, 2017 Filed Mar 16, 2017 20:42 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 44,469 $39.96 $1,776,803.36
Disclosure

SEC source: 0000899243-17-007767 · doc4.xml · nonDerivative · entry 2

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,460,399

Read SEC document
March 14, 2017 Filed Mar 16, 2017 20:42 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 17,252 $40.00 $690,067.92
Disclosure

SEC source: 0000899243-17-007767 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,415,930

Read SEC document
March 10, 2017 Filed Mar 14, 2017 17:29 UTC Radius Health, Inc. RDUS · Entity 124173 PurchaseCommon Stock 38,279 $39.17 $1,499,285.08
Disclosure

SEC source: 0000899243-17-007424 · doc4.xml · nonDerivative · entry 1

BIOTECH GROWTH N V · CIK 0001259869 · 10% owner

BB BIOTECH AG · CIK 0000924223 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,398,678

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.